Related Experiment Videos

[Mitogen activated protein kinases (MAPK) and Toxoplasma gondii host cell invasion]

F Robert-Gangneux1, C Creuzet, J Dupouy-Camet

  • 1Laboratoire Signalisation et Parasites, UPRES EA 2499-INSERM U529, Faculté de Médecine Cochin-Port Royal, Université Paris V, 27, rue du Faubourg St Jacques, F75014 Paris.

Insights

Toxoplasma gondii uses parasite-specific ERK-type kinases to invade host cells. Inhibiting these kinases reduces parasite infectivity, offering new targets for treating toxoplasmosis.

Area of Science:

  • Parasitology
  • Molecular Biology
  • Cell Biology

Context:

  • Toxoplasmosis poses significant public health challenges, particularly congenital and reactivated forms in immunocompromised individuals.
  • Toxoplasma gondii, an obligate intracellular parasite, invades host cells via poorly understood mechanisms.
  • Understanding parasite invasion is crucial for developing effective interventions.

Purpose:

  • To investigate the role of host cell signaling pathways, specifically mitogen-activated protein kinases (MAPK), in Toxoplasma gondii invasion.
  • To characterize parasite MAPK homologues and their activation mechanisms.
  • To determine the impact of MAPK modulation on parasite infectivity.

Summary:

  • Researchers identified and characterized parasite MAPK, likely ERK1 and ERK2, in Toxoplasma gondii.
  • These parasite MAPKs are activated by calcium and phorbolmyristyl acetate, suggesting Protein Kinase C (PKC) involvement, and are dependent on a MEK homologue for activation.
  • Modulating parasite MAPK activity in vitro directly affected host cell invasion, with activation increasing and inhibition decreasing infectivity.

Impact:

  • The findings implicate ERK-type parasite kinases in T. gondii infectivity, suggesting they are critical for the invasion process.
  • This research provides a foundation for developing novel therapeutic strategies targeting parasite kinases to combat toxoplasmosis.
  • Identifying key molecular players in parasite invasion opens avenues for anti-parasitic drug development.

Related Concept Videos